Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.23.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Total KLA Stockholders’ Equity
Common Stock and Capital in Excess of Par Value, Shares
Common Stock and Capital in Excess of Par Value, Amount
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Non- Controlling Interest
Beginning balance (in shares) at Jun. 30, 2021     152,776        
Beginning balance at Jun. 30, 2021 $ 3,375,642 $ 3,377,554   $ 2,175,988 $ 1,277,123 $ (75,557) $ (1,912)
Increase (Decrease) in Stockholders' Equity              
Net income attributable to KLA 1,068,417 1,068,417     1,068,417    
Net income attributable to non-controlling interest 68           68
Other comprehensive income (loss) (2,487) (2,487)       (2,487)  
Net issuance under employee stock plans (in shares)     160        
Net issuance under employee stock plans (46,532) (46,532)   (46,532)      
Repurchase of common stock (in shares)     (1,190)        
Repurchase of common stock (399,677) (399,677)   (16,966) (382,711)    
Cash dividends and dividend equivalents declared (161,561) (161,561)     (161,561)    
Stock-based compensation expense 25,216 25,216   25,216      
Ending balance (in shares) at Sep. 30, 2021     151,746        
Ending balance at Sep. 30, 2021 3,859,086 3,860,930   2,137,706 1,801,268 (78,044) (1,844)
Beginning balance (in shares) at Jun. 30, 2021     152,776        
Beginning balance at Jun. 30, 2021 3,375,642 3,377,554   2,175,988 1,277,123 (75,557) (1,912)
Increase (Decrease) in Stockholders' Equity              
Net income attributable to KLA 2,516,433            
Net income attributable to non-controlling interest 229            
Other comprehensive income (loss) 4,024            
Repurchase of common stock (in shares)     (3,833)        
Repurchase of common stock (1,394,217)            
Ending balance (in shares) at Mar. 31, 2022     149,375        
Ending balance at Mar. 31, 2022 4,078,624 4,080,307   2,179,229 1,972,611 (71,533) (1,683)
Beginning balance (in shares) at Sep. 30, 2021     151,746        
Beginning balance at Sep. 30, 2021 3,859,086 3,860,930   2,137,706 1,801,268 (78,044) (1,844)
Increase (Decrease) in Stockholders' Equity              
Net income attributable to KLA 717,444 717,444     717,444    
Net income attributable to non-controlling interest 73           73
Other comprehensive income (loss) 1,565 1,565       1,565  
Net issuance under employee stock plans (in shares)     205        
Net issuance under employee stock plans 31,157 31,157   31,157      
Repurchase of common stock (in shares)     (1,104)        
Repurchase of common stock (429,874) (429,874)   (15,604) (414,270)    
Cash dividends and dividend equivalents declared (160,461) (160,461)     (160,461)    
Stock-based compensation expense 27,766 27,766   27,766     0
Ending balance (in shares) at Dec. 31, 2021     150,847        
Ending balance at Dec. 31, 2021 4,046,756 4,048,527   2,181,025 1,943,981 (76,479) (1,771)
Increase (Decrease) in Stockholders' Equity              
Net income attributable to KLA 730,572            
Net income attributable to non-controlling interest 88           88
Other comprehensive income (loss) 4,946 4,946       4,946  
Net issuance under employee stock plans (in shares)     67        
Net issuance under employee stock plans (16,661) (16,661)   (16,661)      
Repurchase of common stock (in shares)     (1,539)        
Repurchase of common stock (564,666) (564,666)   (22,222) (542,444)    
Cash dividends and dividend equivalents declared (159,498) (159,498)     (159,498)    
Stock-based compensation expense 37,087 37,087   37,087      
Ending balance (in shares) at Mar. 31, 2022     149,375        
Ending balance at Mar. 31, 2022 4,078,624 4,080,307   2,179,229 1,972,611 (71,533) (1,683)
Beginning balance (in shares) at Jun. 30, 2022     141,804        
Beginning balance at Jun. 30, 2022 1,399,090 1,401,351   1,061,940 366,882 (27,471) (2,261)
Increase (Decrease) in Stockholders' Equity              
Net income attributable to KLA 1,025,991 1,025,991     1,025,991    
Net income attributable to non-controlling interest 74           74
Other comprehensive income (loss) (31,370) (31,370)       (31,370)  
Net issuance under employee stock plans (in shares)     171        
Net issuance under employee stock plans (54,950) (54,950)   (54,950)      
Repurchase of common stock (in shares)     (257)        
Repurchase of common stock (89,616) (89,616)   (1,926) (87,690)    
Cash dividends and dividend equivalents declared (186,216) (186,216)     (186,216)    
Stock-based compensation expense 34,982 34,982   34,982      
Purchase of non-controlling interest (4,294) 1,902   1,902     (6,196)
Disposal of non-controlling interest 8,383           8,383
Ending balance (in shares) at Sep. 30, 2022     141,718        
Ending balance at Sep. 30, 2022 2,102,074 2,102,074   1,041,948 1,118,967 (58,841) 0
Beginning balance (in shares) at Jun. 30, 2022     141,804        
Beginning balance at Jun. 30, 2022 1,399,090 1,401,351   1,061,940 366,882 (27,471) (2,261)
Increase (Decrease) in Stockholders' Equity              
Net income attributable to KLA 2,702,623            
Net income attributable to non-controlling interest 74            
Other comprehensive income (loss) (7,820)            
Repurchase of common stock (in shares)     (4,913)        
Repurchase of common stock (943,310)            
Ending balance (in shares) at Mar. 31, 2023     137,289        
Ending balance at Mar. 31, 2023 2,682,781 2,682,781   1,996,773 721,299 (35,291) 0
Beginning balance (in shares) at Sep. 30, 2022     141,718        
Beginning balance at Sep. 30, 2022 2,102,074 2,102,074   1,041,948 1,118,967 (58,841) 0
Increase (Decrease) in Stockholders' Equity              
Net income attributable to KLA 978,795 978,795     978,795    
Other comprehensive income (loss) 9,739 9,739       9,739  
Net issuance under employee stock plans (in shares)     170        
Net issuance under employee stock plans 31,196 31,196   31,196      
Repurchase of common stock (in shares)     (3,429)        
Repurchase of common stock (370,982) (370,982)   870,811 (1,241,793)    
Cash dividends and dividend equivalents declared (185,967) (185,967)     (185,967)    
Stock-based compensation expense 38,405 38,405   38,405      
Ending balance (in shares) at Dec. 31, 2022     138,459        
Ending balance at Dec. 31, 2022 2,603,260 2,603,260   1,982,360 670,002 (49,102) 0
Increase (Decrease) in Stockholders' Equity              
Net income attributable to KLA 697,837 697,837     697,837    
Net income attributable to non-controlling interest 0            
Other comprehensive income (loss) 13,811 13,811       13,811  
Net issuance under employee stock plans (in shares)     57        
Net issuance under employee stock plans (16,154) (16,154)   (16,154)      
Repurchase of common stock (in shares)     (1,227)        
Repurchase of common stock (482,712) (482,712)   (17,563) (465,149)    
Cash dividends and dividend equivalents declared (181,391) (181,391)     (181,391)    
Stock-based compensation expense 48,130 48,130   48,130      
Ending balance (in shares) at Mar. 31, 2023     137,289        
Ending balance at Mar. 31, 2023 $ 2,682,781 $ 2,682,781   $ 1,996,773 $ 721,299 $ (35,291) $ 0